The menopause and HRT. Urogenital effects of hormone therapy

Best Practice & Research. Clinical Endocrinology & Metabolism
Dudley Robinson, L Cardozo

Abstract

The urogenital tract and lower urinary tract are sensitive to the effects of oestrogen and progesterone throughout adult life. Epidemiological studies have implicated oestrogen deficiency in the aetiology of lower urinary tract symptoms occurring following the menopause. Although to date the role of oestrogen replacement therapy in the management of post-menopausal urinary incontinence remains controversial, its use in the management of women complaining of urogenital atrophy is now well established. This aim of this chapter is to review the recent evidence regarding the urogenital effects of hormone therapy with a particular emphasis on the management of post-menopausal urinary incontinence, recurrent lower urinary tract infections and urogenital atrophy.

References

Jan 1, 1976·Urologia Internationalis·F SchreiterK Stockamp
Apr 21, 1992·European Journal of Obstetrics, Gynecology, and Reproductive Biology·P S Eriksen, H Rasmussen
May 1, 1992·Age and Ageing·A L KokJ Janssens
Jun 1, 1992·Scandinavian Journal of Primary Health Care·A L KirkengenE Bodd
Mar 1, 1990·Journal of the American Geriatrics Society·J G Ouslander
Jun 1, 1987·British Journal of Obstetrics and Gynaecology·P D WilsonA D Brown
Jan 1, 1987·Acta Obstetricia Et Gynecologica Scandinavica·U UlmstenA Malmström
Jan 1, 1981·Acta Obstetricia Et Gynecologica Scandinavica·A Ingelman-SundbergK Carlström
Jan 1, 1984·Acta Obstetricia Et Gynecologica Scandinavica·C S Iosif, Z Bekassy
Mar 1, 1981·Journal of Epidemiology and Community Health·J W YarnellT P Stephenson
Nov 8, 1980·British Medical Journal·T M ThomasT W Meade
Dec 1, 1994·Maturitas·C J Sultana, M D Walters
Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·G G KuiperJ A Gustafsson
Jun 3, 1998·British Journal of Obstetrics and Gynaecology·L CardozoD Abbott
Jun 16, 1999·Current Opinion in Obstetrics & Gynecology·M WarnerJ A Gustafsson
Mar 30, 2000·International Urogynecology Journal and Pelvic Floor Dysfunction·J M van GeelenH T Arnolds
Aug 24, 2000·BJOG : an International Journal of Obstetrics and Gynaecology·G Lose, E Englev
Jan 12, 2001·Obstetrics and Gynecology·D GradyUNKNOWN HERS Research Group
Feb 24, 2001·BJOG : an International Journal of Obstetrics and Gynaecology·A H MacLennanD Wilson
Apr 11, 2001·International Urogynecology Journal and Pelvic Floor Dysfunction·L CardozoH de Koning Gans
May 26, 2001·International Urogynecology Journal and Pelvic Floor Dysfunction·E VersiJ W Studd

❮ Previous
Next ❯

Citations

Apr 13, 2007·International Urogynecology Journal and Pelvic Floor Dysfunction·G Alessandro DigesuVik Khullar
Oct 22, 2014·Climacteric : the Journal of the International Menopause Society·R E NappiJ A Simon
Aug 17, 2006·BJU International·Michael AlboFirouz Daneshgari
Aug 9, 2005·Fertility and Sterility·Erin F WolffHugh S Taylor
Jan 5, 2006·Climacteric : the Journal of the International Menopause Society·C KoebnickK O'Doherty Jensen
Oct 5, 2010·Climacteric : the Journal of the International Menopause Society·D W SturdeeUNKNOWN International Menopause Society Writing Group
Apr 24, 2009·Climacteric : the Journal of the International Menopause Society·J Calleja-Agius, M P Brincat
Jan 13, 2004·Menopause : the Journal of the North American Menopause Society·Kristen Eckler
Sep 7, 2018·Neurourology and Urodynamics·Allert M de VriesJohn P F A Heesakkers

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.